Pearinda Plus 8 8 mg Tablets.
PDF Leaflet Revision Date: 09 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of essential hypertension.
Dosage (summary)
One tablet daily, preferably in the morning before a meal.
Onset of Action / Duration
Onset: 4-6 hours, Duration: 24 hours
Special Populations
- Elderly: start with one constituent
- Renal impairment: contraindicated if creatinine clearance <30 mL/min
- Hepatic impairment: contraindicated in severe cases
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Lithium: increased toxicity risk
- Aliskiren: contraindicated in renal impairment
- Potassium-sparing diuretics: risk of hyperkalaemia
Contraindications
- Hypersensitivity to perindopril or indapamide
- Severe renal impairment
- Pregnancy and lactation
Common side effects
- Dizziness
- Hypotension
- Cough
- Hypokalaemia
Counselling Points
- Take in the morning before meals
- Do not double dose if missed
- Report signs of infection or allergic reactions
Serious warnings
- Risk of angioedema
- Monitor renal function and potassium levels
- Caution in patients with renal artery stenosis
Important Disclaimer
The Pearinda Plus 8 8 mg Tablets. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
